Positron Corporation (POSC)

[Bayou Man]

'POSC' - (Positron Reports Substantial Interest in Its Attrius Dedicated Cardiac PET Scanner)

May 25, 2010 (Close-Up Media via COMTEX) -- Positron Corp., a molecular imaging
solutions company focused on Nuclear Cardiology, said that over the first 4
months of 2010 it has seen tremendous interest in its Attrius dedicated cardiac
PET scanner.

The Attrius was introduced in the 4th quarter of 2009 and has been met with
critical acclaim throughout the molecular imaging industry.

Patrick G. Rooney, Positron Corp.'s CEO said, "The Nuclear Cardiology industry
is experiencing a shift from SPECT to PET as a result of molly shortages
combined with changes in reimbursement. Positron is in an ideal position to
capitalize on this shift more so than any other imaging company. The Attrius is
a state of the art, Frost & Sullivan New Product Innovation Award winning,
device that was designed to be optimized for Cardiac imaging allowing physicians
an easy transition to PET. Our pipeline for PET systems has had significant
increases each month since we launched the Attrius late last year. Our current
pipeline has over 55 potential and/or pending sales with the second half on the
year still too follow. We have done a very good job of positioning Positron to
meet this new demand. Based on the current interest we believe we will meet or
exceed our projected system sales moving forward. Positron's objective is to be
the leader in cardiac PET solutions. We believe we will continue to see
substantial growth from both devices and radiopharmaceuticals."

((Comments on this story may be sent to [e-mail]))




Copyright Close-Up Media, Inc. 2010. All Rights reserved

-0-




INDUSTRY KEYWORD: Health_And_Beauty_Close-up